Published in Hum Toxicol on October 01, 1983
Clinical toxicology. Postgrad Med J (1993) 0.90
Markedly Elevated Carbamazepine-10,11-epoxide/Carbamazepine Ratio in a Fatal Carbamazepine Ingestion. Case Rep Med (2015) 0.77
Bio-availability of three formulations of glibenclamide. S Afr Med J (1989) 1.39
Experience with the intensive care management of organophosphate insecticide poisoning. S Afr Med J (1981) 1.12
Lack of effect of pantoprazole on the pharmacodynamics and pharmacokinetics of warfarin. Br J Clin Pharmacol (1995) 0.94
The pharmacology of recombinant hirudin, a new anticoagulant. S Afr Med J (1990) 0.92
South African multicentre trial with Voltaren in osteo-arthritis of the knee. S Afr Med J (1974) 0.90
Increased frequency of the transferrin C2 subtype in Alzheimer's disease. Neuroreport (1993) 0.88
Caffeine in sport. Urinary excretion of caffeine in healthy volunteers after intake of common caffeine-containing beverages. S Afr Med J (1988) 0.88
Pharmacokinetics of acarbose. Part I: Absorption, concentration in plasma, metabolism and excretion after single administration of [14C]acarbose to rats, dogs and man. Arzneimittelforschung (1989) 0.86
The effects of forskolin eye drops on intra-ocular pressure. S Afr Med J (1987) 0.86
Does cimetidine alter the cardiac response to exercise and propranolol? S Afr Med J (1979) 0.85
A correlative study of serum digoxin levels and electrocardiographic measurements. S Afr Med J (1975) 0.85
Penbutolol and furosemide in a fixed-dose combination-bio-equivalence of two formulations. S Afr Med J (1981) 0.85
Single and divided doses of penbutolol. Clin Pharmacol Ther (1979) 0.85
A multicentre trial of Voltaren in the treatment of rheumatoid Arthritis. S Afr Med J (1974) 0.84
Pharmacokinetic and pharmacodynamic implications of long-term administration of non-steroidal anti-inflammatory agents. Int J Clin Pharmacol Biopharm (1977) 0.84
International standardization of glycohemoglobin measurements: practical application. Clin Chem (1993) 0.83
Sensitive liquid chromatographic-tandem mass spectrometric method for the determination of fluoxetine and its primary active metabolite norfluoxetine in human plasma. J Chromatogr A (2001) 0.83
Pharmacokinetics of ramipril in the elderly. Am J Cardiol (1987) 0.83
Efficacy and tolerability of nisoldipine coat-core formulation in the treatment of essential hypertension: The South African Multicenter ANCHOR Study. Ambulatory Nisoldipine Coat-Core Hypertension Outpatient Response (ANCHOR) Investigators. Am J Hypertens (1997) 0.82
The microbial metabolism of condensed (+)-catechins by rat-caecal microflora. Xenobiotica (1986) 0.82
Comparative bio-availability of four formulations of furosemide. S Afr Med J (1985) 0.82
The effect of penbutolol on glomerular filtration. S Afr Med J (1981) 0.81
Absolute bioavailability of a new high dose methylprednisolone tablet formulation. Int J Clin Pharmacol Ther (1994) 0.80
No pharmacokinetic or pharmacodynamic interaction between rivastatin and warfarin. J Clin Pharmacol (1995) 0.80
Influence of meloxicam on furosemide pharmacokinetics and pharmacodynamics in healthy volunteers. Eur J Clin Pharmacol (1995) 0.80
Sensitive liquid chromatography-tandem mass spectrometry method for the determination of loratadine and its major active metabolite descarboethoxyloratadine in human plasma. J Chromatogr A (2001) 0.80
High-performance liquid chromatographic determination with amperometric detection of piroxicam in human plasma and tissues. J Chromatogr B Biomed Sci Appl (1999) 0.80
Relative bioavailability of four clomipramine hydrochloride tablet products. Biopharm Drug Dispos (1996) 0.79
The effect of fasting on total serum bilirubin concentrations. Br J Clin Pharmacol (1995) 0.79
Pharmacokinetic aspects of the interaction between clobazam and cimetidine. Eur J Clin Pharmacol (1983) 0.79
Ibuprofen bio-availability. A comparison of Brufen and Inza. S Afr Med J (1986) 0.78
The pharmacokinetics of a single intravenous dose of metronidazole in pregnant patients. J Antimicrob Chemother (1984) 0.78
Paracetamol overdose: protective effect of concomitantly ingested antimuscarinic drugs and codeine. Hum Toxicol (1983) 0.78
Aflatoxin exposure and its relationship to kwashiorkor in African children. J Trop Pediatr (1991) 0.78
Severe mefenamic acid poisoning. A case report. S Afr Med J (1985) 0.78
The microbial metabolism of (+)-catechin to two novel diarylpropan-2-ol metabolites in vitro. Xenobiotica (1984) 0.78
The effect of benzbromarone on allopurinol/oxypurinol kinetics in patients with gout. Eur J Clin Pharmacol (1993) 0.78
Pharmacokinetic characteristics for extent of absorption and clearance in drug/drug interaction studies. Int J Clin Pharmacol Ther (1994) 0.78
Letter: Ethyl alcohol: contamination of blood specimens. S Afr Med J (1976) 0.78
Lack of interaction between ramipril and simvastatin. Eur J Clin Pharmacol (1994) 0.77
An evaluation of the interaction of meloxicam with frusemide in patients with compensated chronic cardiac failure. Br J Clin Pharmacol (1997) 0.77
Effects of tendamistate on postprandial plasma glucose, free fatty acid and triglyceride levels. S Afr Med J (1984) 0.77
Inhibition of starch absorption by tendamistate (an alpha-amylase inactivator). S Afr Med J (1983) 0.76
Inhibition of starch absorption by alpha-amylase inactivator given with food. Lancet (1983) 0.76
A comparison of the pharmacokinetics of metronidazole in man after oral administration of single doses of benzoylmetronidazole and metronidazole. Br J Clin Pharmacol (1982) 0.76
Multiple doses of trandolapril do not affect warfarin pharmacodynamics. S Afr Med J (1995) 0.76
Relative bioavailability of rifampicin, isoniazid and ethambutol from a combination tablet vs. concomitant administration of a capsule containing rifampicin and a tablet containing isoniazid and ethambutol. Arzneimittelforschung (1995) 0.76
Availability of phendimetrazine from sustained and non-sustained action formulations. S Afr Med J (1975) 0.76
No influence of pantoprazole on the pharmacokinetics of phenytoin. Int J Clin Pharmacol Ther (1995) 0.76
Salivary digoxin concentrations. Br J Clin Pharmacol (1976) 0.75
Pharmacokinetics of temazepam after day-time and night-time oral administration. Eur J Clin Pharmacol (1987) 0.75
Digoxin concentrations in serum and saliva: relationship to ECG changes and dosage in healthy volunteers. Br J Clin Pharmacol (1976) 0.75
Effects of tendamistate (alpha-amylase inactivator) on starch metabolism. Br J Clin Pharmacol (1983) 0.75
Double-blind randomized cross-over trial of nocturnal elixir theophylline supplementation of a twice-daily sustained-release theophylline tablet formulation in asthmatic patients. Chronobiol Int (1993) 0.75
No influence of pantoprazole on the pharmacokinetics of phenytoin. Int J Clin Pharmacol Ther (1996) 0.75
Physostigmine and the adrenergic/antimuscarinic syndrome. A case report. S Afr Med J (1984) 0.75
Epidural fentanyl in the management of postoperative pain. S Afr Med J (1986) 0.75
Statistical significance versus clinical relevance. Part II. The use and interpretation of confidence intervals. S Afr Med J (1989) 0.75
Carbamazepine and its major metabolites in plasma: a summary of eight years of therapeutic drug monitoring. Ther Drug Monit (1983) 0.75
Drugs in sport. The first 5 years of testing in South Africa. S Afr Med J (1988) 0.75
Assessing the risk of ovulation in interaction studies of drugs and oral contraceptives. Int J Clin Pharmacol Ther Toxicol (1993) 0.75
Steady-state pharmacokinetics of phentermine extended-release capsules. Int J Clin Pharmacol Ther Toxicol (1993) 0.75
The metabolism of atropine in man. J Pharm Pharmacol (1986) 0.75
Dettol (chloroxylenol and terpineol) poisoning in a pregnant patient. A case report. S Afr Med J (1984) 0.75
Antagonism of diazepam by aminophylline in healthy volunteers. Anesth Analg (1984) 0.75
Effects of HOE 760 (histamine H2-receptor antagonist) on diazepam pharmacokinetics. S Afr Med J (1988) 0.75
Ingestion of codeine and salicylic acid causing convulsions and coma. A case report. S Afr Med J (1984) 0.75
Statistical significance versus clinical relevance. Part III. Methods for calculating confidence intervals. S Afr Med J (1989) 0.75
Minimization--a method of obtaining comparable groups in clinical trials. S Afr Med J (1984) 0.75
Beta-aryl-alpha-oxoglutaric acids. J Chem Soc Perkin 1 (1966) 0.75
The effects of felodipine on the pharmacokinetics of diazepam. Int J Clin Pharmacol Ther Toxicol (1992) 0.75
Effects of piretanide on potassium balance in hypertension. S Afr Med J (1985) 0.75
Study of the effect of miglitol on the pharmacokinetics and pharmacodynamics of warfarin in healthy males. Arzneimittelforschung (1996) 0.75
Inhibition of atropine metabolism by organophosphate pesticides. Hum Toxicol (1983) 0.75
Pharmacokinetics of aprotinin in two patients with chronic renal impairment. Br J Clin Pharmacol (1996) 0.75
Effects of tendamistate (an alpha-amylase inactivator), guar and placebo on starch metabolism. S Afr Med J (1984) 0.75
Pharmacodynamics and tolerability of low doses of tendamistate given with starch. S Afr Med J (1984) 0.75
Relative bioavailability of four controlled-release nifedipine products. Biopharm Drug Dispos (1994) 0.75
Theophylline dose-concentration relationship of a 12-hourly Nuelin SA regimen supplemented with nocturnal nuelin liquid in healthy volunteers. Chronobiol Int (1993) 0.75
Accurate placement of a lumbar epidural cannula without epidurograms. S Afr Med J (1983) 0.75
Pharmacodynamics and urine pharmacokinetics of three doses of piretanide. Eur J Clin Pharmacol (1983) 0.75
Comparative bio-availability of theophylline whole and halved sustained-release tablets. S Afr Med J (1987) 0.75
Oxprenolol plus ethanol causes no central nervous system depression--a comparison with lorazepam plus ethanol. S Afr Med J (1984) 0.75
Acute oral loading of carbamazepine-CR and phenytoin in a double-blind randomized study of patients at risk of seizures. Epilepsia (1994) 0.75
Considerable cost savings through the analysis of pooled plasma samples in bioequivalence studies that fail to show bioequivalence. Int J Clin Pharmacol Ther Toxicol (1993) 0.75
Bioequivalence of controlled-release calcium antagonists. Clin Pharmacokinet (1997) 0.75